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Abstract
Aims/hypothesis South Asians are up to four times more
likely to develop type 2 diabetes than white Europeans. It is
postulated that the higher prevalence results from greater
genetic risk. To evaluate this hypothesis, we: (1) systematical-
ly reviewed the literature for single nucleotide polymorphisms
(SNPs) predisposing to type 2 diabetes in South Asians; (2)
compared risk estimates, risk alleles and risk allele frequencies
of predisposing SNPs between South Asians and white Euro-
peans; and (3) tested the association of novel SNPs discovered
from South Asians in white Europeans.
Methods MEDLINE, Embase, the Cumulative Index to Nurs-
ing and Allied Health Literature (CINAHL) and the Cochrane
registry were searched for studies of genetic variants associ-
ated with type 2 diabetes in South Asians. Meta-analysis
estimates for common and novel bi-allelic SNPs in South
Asians were compared with white Europeans from the DIA-
betes Genetics Replication And Meta-analysis (DIAGRAM)
consortium. The population burden from predisposing SNPs
was assessed using a genotype score.
Results Twenty-four SNPs from 21 loci were associated with
type 2 diabetes in South Asians after meta-analysis. The
majority of SNPs increase odds of the disorder by
15–35% per risk allele. No substantial differences appear to
exist in risk estimates between South Asians and white
Europeans from SNPs common to both groups, and the pop-
ulation burden also does not differ. Eight of the 24 are novel
SNPs discovered from South Asian genome-wide association
studies, some of which show nominal associations with type 2
diabetes in white Europeans.
Conclusions/interpretation Based on current literature
there is no strong evidence to indicate that South Asians
possess a greater genetic risk of type 2 diabetes than
white Europeans.
Keywords Epidemiology . Ethnicity . Genetic risk .
Meta-analysis . South Asian . Type 2 diabetes .White
Europeans
Abbreviations
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HWE Hardy–Weinberg equilibrium
LD Linkage disequilibrium
RAF Risk allele frequency
SNP Single nucleotide polymorphism
Electronic supplementary material The online version of this article
(doi:10.1007/s00125-014-3354-1) contains peer-reviewed but unedited
supplementary material, which is available to authorised users.
Z. N. Sohani :W. Q. Deng :G. Pare :D. Meyre :H. C. Gerstein :
S. S. Anand (*)
Population Genomics Program, Department of Clinical
Epidemiology and Biostatistics, McMaster University,
1280 Main St W, Hamilton, ON, Canada L8S 4L8
e-mail: anands@mcmaster.ca
Z. N. Sohani :W. Q. Deng :G. Pare :D. Meyre : S. S. Anand
Chanchlani Research Centre, McMaster University,
Hamilton, ON, Canada
Z. N. Sohani :W. Q. Deng :G. Pare :D. Meyre :H. C. Gerstein :
S. S. Anand
Population Health Research Institute, Hamilton Health Sciences,
Hamilton, ON, Canada
G. Pare :D. Meyre
Department of Pathology and Molecular Medicine, McMaster
University, Hamilton, ON, Canada
H. C. Gerstein : S. S. Anand





Type 2 diabetes is a metabolic disorder resulting from the
interplay between insulin secretion and action. The prevalence
of type 2 diabetes is increasing globally [1]. Currently, there are
61 million people with diabetes in the Indian subcontinent, a
number that will rise to 100 million by the year 2030,
representing 25% of the world’s burden [2, 3]. South Asians
develop metabolic abnormalities, such as hyperglycaemia, low
HDL-cholesterol, and elevated triacylglycerol, at a lower BMI
and younger age than white Europeans [4–6]. It is hypothesised
that the higher prevalence of type 2 diabetes results from a
greater genetic predisposition among South Asians [7, 8], either
because of larger risk estimates for each single nucleotide
polymorphism (SNP) or increased frequency of risk alleles.
This hypothesis has not been systematically evaluated.
The purpose of this systematic review is to: (1) establish
risk estimates for SNPs predisposing South Asians to type 2
diabetes; (2) compare risk estimates, risk alleles and risk allele
frequencies (RAFs) of type 2 diabetes predisposing SNPs
between South Asians and white Europeans; and (3) explore
the association of novel SNPs discovered from South Asians
in a large cohort of white Europeans.
Methods
Systematic review of studies assessing genetic risk of type 2
diabetes in South Asians
Search strategy and selection criteria MEDLINE, Embase,
the Cumulative Index to Nursing and Allied Health Literature
(CINAHL) and the Cochrane registry (from inception to 17 June
2013; MEDLINE and Embase searched using OvidSP) were
searched for studies of genetic variants associated with type 2
diabetes in South Asians. South Asians were defined as individ-
uals originating from India, Pakistan, Bangladesh or Sri Lanka.
The search strategy was developed in consultation with a re-
search librarian and did not restrict by type of genetic variant,
language of study or study design (i.e. case–control, cohort,
cross-sectional). The full search strategy is presented in electronic
supplementary material (ESM) Table 1. Experts were consulted,
and reference lists of included articles as well as relevant exclud-
ed articles were searched. Two reviewers (ZNS and WQD)
independently assessed each study for eligibility based on four
questions: (1) is at least one study population South Asian; (2) is
type 2 diabetes the outcome studied; (3) is the exposure a genetic
variant; and (4) is this a genetic association study?Disagreements
were independently resolved by a third reviewer (SSA). Articles
that passed the screening phase were reviewed in depth.
Full-text review and data extraction Conference abstracts,
narrative reviews and other systematic reviews were excluded
after full-text review. Primary studies investigating genetic
variants other than bi-allelic SNPs (e.g. insertions, deletions,
length polymorphisms, haplotypes and complex tri-allelic
SNPs) or with fewer than 25 cases were excluded. These
restrictions were implemented to ensure that included studies
could be combined and were of sound quality. Additionally, to
ensure robustness of our results, SNPs from included studies
carried forward to meta-analysis were limited to those that
previously reached genome-wide significance in any ethnicity.
If datasets were publishedmore than once, publication with the
largest sample size or the one recommended by the senior
author was used for meta-analysis. Two reviewers conducted
a full-text assessment and extracted data on participant char-
acteristics (sample size, age, BMI, fasting glucose, waist and
hip circumferences and % men), study design (study methods,
region) and results (SNP, risk allele, RAF in cases and controls,
and risk estimate with a 95% CI). For genome-wide associa-
tion studies (GWAS) in South Asians, SNPs associated with
type 2 diabetes at p<10−3 were considered for meta-analysis.
Quality assessment of included studies Using recommenda-
tions from the STrengthening the REporting of Genetic Asso-
ciation Studies (STREGA) guidelines [9], the following three
components were considered for quality assessment: testing
for Hardy–Weinberg equilibrium (HWE) in controls [10],
reporting of genotyping call rate or appraisal of genotyping
quality by duplication, and sources of case and control
ascertainment.
Statistical analysis Agreement between reviewers was report-
ed with Cohen’s κ statistic. Allelic ORs were calculated using
RAFs and sample size for cases and controls and assessed for
significance using Fisher’s exact test. The ORs were not
adjusted for any covariates. ORs for SNPs in linkage disequi-
librium (LD) (r2>0.8) obtained from independent cohorts
were meta-analysed using a random-effects model weighted
by inverse variance. LD was estimated using 1000 Genome
Centre d'Etude du Polymorphisme (CEU) (Utah residents
with northern and western European ancestry) data from
SNAP (Broad Institute, Cambridge, MA, USA) [11]. A two-
sided α level of 0.05 was considered significant. For a list of
SNPs in LD, see ESM Table 2. Summary RAFs are presented
as averages, weighted by sample size, of all included reports.
Heterogeneity was estimated using I2 statistic, which indicates
the proportion of total variation in estimates attributed to
heterogeneity, as well as the Q statistic [12]. A cut-off of
25% for I2 was used to represent minimal heterogeneity,
50% to represent moderate and 75% to represent high hetero-
geneity. Quanto, Los Angeles, CA, USA (version 1.2.4) was
used for sample size and power calculations assuming a
disease prevalence of 10% and an additive model of inheri-
tance. All other statistical analyses were conducted in R
(version 3.0.2).
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Comparison of meta-analysed SNPs in South Asians
with white Europeans
Estimates for SNPs associated with type 2 diabetes in this
meta-analysis were retrieved for white Europeans from the
DIAbetes Genetics Replication And Meta-analysis
(DIAGRAM) consortium. Specific details on the consortium
have been previously described [13]. Briefly, DIAGRAM
stage 1 is a publicly available database of 12 GWAS with
12,171 cases and 56,862 controls. DIAGRAM authors tested
SNPs with minor allele frequency >1% for association with
type 2 diabetes under an additive model. The authors com-
bined summary estimates from the 12 GWAS using fixed-
effect inverse-variance-weighted meta-analysis.
Effect sizes from white Europeans in DIAGRAM and
South Asians from this meta-analysis were transformed to
natural logs and compared using a Z test. RAFs in white
Europeans were acquired from published GWAS (www.
genome.gov/gwastudies/). Additionally, a genotype score of
SNPs present in both groups was constructed to compare
population burden from these SNPs. The genotype score
was constructed as below:
Genotype score ¼ Σ loge ORið Þ  RAFi½ 
Variance for the genotype score was estimated as:
Variance ¼ Σ RAFi2  variance loge ORið Þ½ 
 
Genotype scores from both ethnicities were compared
using a Z test.
Testing novel SNPs discovered from South Asians GWAS
in white Europeans
Four GWAS have been conducted in South Asians [14–17],
which collectively identified nine SNPs ( p<5×10−8). All
studies used a case–control design. Associations with type 2
diabetes for eight of the nine SNPs have not been indepen-
dently discovered from GWAS in any other ethnicity. We
compared the association for these eight novel SNPs with
type 2 diabetes in white Europeans from DIAGRAM. An
overview of the study design is presented in Fig. 1a.
Results
Systematic review and meta-analysis
Search yields A total of 3,898 articles were originally
screened, of which 170 were carried to full-text review.
Ninety-four studies met the inclusion and exclusion criteria,
and 38 studies comprising 31 independent cohorts contained
data on SNPs with evidence of genome-wide significance in
any ethnicity. These 38 studies were included in the systematic
review. Figure 1b depicts the selection process and lists
reasons for exclusion at each stage. There was excellent
agreement on study inclusion between reviewers (unweighted
κ=0.898).
Study characteristics All included studies were in English
and published in 2004 or later. Most large datasets (>2,500
people) were published after 2008. Eight of the 31 cohorts
were from North India, four from South India, five from
Pakistan, one from the Eastern region (Orissa), four from
Indians residing in Singapore, two from Sri Lanka, one from
Indians residing in Trinidad, one from Indians residing in
Mauritius and one from all over the South Asian subcontinent;
four were unspecified.
Participant characteristics Studies eligible for analysis in-
cluded 29,618 cases and 40,329 controls. Controls were de-
scribed as healthy individuals whowere normoglycaemic and/
or non-diabetic. Men accounted for 54% of cases and 53% of
controls. Age ranged from 34 to 62 years in cases [18, 19], and
from 28 to 62 years in controls [18, 20]. BMI was reported for
cases and controls in 79% of studies and ranged from 25.0 to
31.9 kg/m2 in cases [21, 22] and from 19.4 to 28.1 kg/m2 [23,
24] in controls. A majority of studies reported fasting glucose:
58% in cases (ranging from 6.41 to 10.60mmol/l) [25, 26] and
63% in controls (ranging from 4.60 to 6.89 mmol/l) [14, 27].
Very few datasets reported additional clinical information;
29% reported waist circumference in cases and controls. Only
three studies reported hip circumference. ESM Table 3 pro-
vides a summary of all included studies.
Quality assessment Agreement with HWE in controls,
genotyping call rate and source of controls and cases for
included studies are summarised in ESM Table 4. One study
did not report compliance with HWE [28]. SNPs in one study
deviated from HWE [29]; rs2237892 and rs2237897 deviated
from HWE at p=0.002 and p=0.001, respectively. The SNPs
were excluded from analysis because the HWE threshold in
the primary report was fairly conservative. Six studies did not
appraise genotyping quality [28, 30–34]. Furthermore, three
studies had a genotyping call rate below 95% for all reported
SNPs [29, 35, 36].
Risk estimates for SNPs associated with type 2 diabetes in
South Asians Thirty SNPswith previous evidence of genome-
wide significance in other ethnicities were available for meta-
analysis. Pooled estimates were significant for 15 of the 30
SNPs (Fig. 2). Summary ORs, on the whole, suggested be-
tween a 1.15- and a 1.35-fold increase in susceptibility for
type 2 diabetes per risk allele. Surprisingly, the risk alleles for
both KCNQ1 polymorphisms substantially increased the odds
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of type 2 diabetes (rs2237892 OR 1.62, 95% CI 1.01–2.59;
rs2237897 OR 2.19, 95% CI 1.25–3.82). High degrees of
between-study heterogeneity were evident for CDKAL1
rs7754840 (I2=70%, Q=19.99, p<0.01) and TCF7L2
rs7903146 (I2=90%, Q=99.52, p<0.01). In the TCF7L2 me-
ta-analysis, there was some evidence that larger studies had
more conservative estimates, although Chauhan et al [35] and
Uma Jyothi et al [25] were exceptions. The smallest study (n=
40 case/control pairs) depicted an association that was
directionally inconsistent with the others [22]. Heteroge-
neity estimates did not change much without this outlier
(I2=90%, Q=90.31, p<0.01). Additional sources of het-
erogeneity could include consanguinity [34, 37]. One
very obvious outlier existed in the meta-analysis for
CDKAL1 (OR 2.22, 95% CI 1.64–2.98) [37]. Heteroge-
neity estimates without this outlier diminished
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Fig. 1 (a) Overview of the study
design. (b) Flow diagram of the
systematic review of South Asian
literature investigating genetic
variants predisposing to type 2
diabetes (first objective of study).
T2DM, type 2 diabetes mellitus
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substantially (I2=0%, Q=2.80, p=0.73). None of the
outliers was excluded from our final analysis.
A majority of genes associated with type 2 diabetes from
this meta-analysis (ADCY5, CDKAL1, CDKN2A/B, HHEX,
IGF2BP2, SLC30A8, TCF7L2 and KCNQ1) are involved in
pancreatic beta cell function, while two are implicated in
insulin sensitivity (PPARG) and adiposity (FTO). This is not
surprising as insulin secretion is a more heritable trait than
insulin action [38]. In addition to the above, eight novel SNPs
were identified from South-Asian-only GWAS; these are
discussed later in this paper.
Comparison of effect sizes, RAF, and risk alleles
between South Asians and white Europeans
Meta-analysis estimates in South Asians were compared with
white Europeans from DIAGRAM; no significant differences
were identified for most SNPs ( p<0.05) (Fig. 2), although
two SNPs showed heterogeneity (KCNQ1 rs2237897 and
IGF2BP2 rs4402960). South Asians had a slightly smaller
OR for IGF2BP2 rs4402960 (South Asians: 1.07, 95% CI
1.04−1.09; white Europeans: 1.13, 95% CI 1.09−1.17).
Figure 3 presents a Venn diagram of overlapping type 2
diabetes predisposing genes in South Asians and white Euro-
peans, as well as genes unique to both groups.
Variation in RAFs between South Asians and white Euro-
peans was observed, but no consistent trend was evident;
South Asians did not consistently have an RAF greater than
white Europeans (Fig. 2). While the risk allele for HHEX was
the same in both ethnicities, the RAF differed; the risk allele is
the minor allele in South Asians, but the major/common allele
in white Europeans. Risk alleles for six SNPs (SLC30A8
rs13266634, ADCY5 rs11708067, PPARG rs1801282,
CHCHD9 (also known asCHCHD2P9) rs13292136,KCNQ1
rs2237897 andCDKN2A/B rs10811661) were major/common
alleles in both ethnicities.
Testing novel SNPs discovered from South Asian GWAS
in white Europeans
The systematic review included four GWAS in South Asians,
which identified nine SNPs associated with type 2 diabetes at
genome-wide significance. With the exception of HMG20A
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Fig. 2 Forest plot of SNPs associated with type 2 diabetes in South Asians and comparison with white Europeans fromDIAGRAM. Chr, chromosome;
het, heterogeneity; no., number; SA, South Asian; WC, white European
European OR: 1.08, 95% CI 1.05–1.10) [14, 39], the remain-
ing eight SNPs have not been discovered in any other ethnic
group. Five of the eight (GRB14 rs3923113, VPS26A
rs1082295, HNF4α [also known as HNF4A] rs4812829,
ST6GAL1 rs16861329, and AP3S2 rs2028299) were indepen-
dently replicated in South Asians [15].
We tested the eight novel SNPs for association with type 2
diabetes in DIAGRAM. SGCG rs9552911 was monomorphic
in white Europeans. The remaining SNPs were directionally
consistent with South Asian estimates and three (AP3S2
rs2028299, GRB14 rs3923113 and HNF4α rs4812829) were
nominally ( p<0.05) associated with type 2 diabetes (Table 1)
in DIAGRAM. The other four were not associated with type 2
diabetes in white Europeans. No consistent trend in RAFs was
observed. The risk allele for TMEM163 rs6723108 is the same
in both ethnicities, but the RAF differs. Specifically, the risk
allele is the minor allele in white Europeans, but the major/
common allele in South Asians.
Population burden
All sixteen SNPs, which were significantly associated with
type 2 diabetes in South Asians, were included in the genotype
score (ADCY5, CDKAL1 rs7754840 and rs7756992,
CDKN2A/2B, FTO, GLIS3, HHEX, PPARG, SLC30A8,
TCF7L2 rs7903146 and rs12255372, CHCHD9, KCNQ1
rs2237892 and rs2237897, IGF2BP2 and HMG20A SNPs
from Table 1 and Fig. 2). RAFs for both ethnicities were
weighed by white European summary ORs from DIAGRAM
because our primary analysis showed that individual risk
estimates did not vary, and due to a larger sample, we expect
the white European estimates to be more precise. Using this
approach, no difference in the population burden was ob-
served ( p=0.85) (Fig. 4).
Discussion
Twenty-four SNPs were associated with type 2 diabetes in
South Asians, eight of which were novel, discovered from
GWAS. There were some variations in RAFs but the effect
sizes for common SNPs did not differ between the ethnic
groups. Interestingly, only three of the novel SNPs discovered
from the South Asian GWAS were nominally associated with
type 2 diabetes in white Europeans. Overall, the population
burden from type 2 diabetes SNPs estimated using a genotype
score appears to be comparable in both ethnicities.
SNPs associated with type 2 diabetes from meta-analysis
of South Asian studies
Meta-analysis of risk alleles for most SNPs increased the odds
of type 2 diabetes by 15–35% among South Asians. Notable
exceptions were the KCNQ1 SNPs, which showed prominent
ORs for type 2 diabetes. KCNQ1 SNPs have been shown as a
more significant contributor to type 2 diabetes than other loci
in other Asian populations [40] and because both SNPs (in
weak LD) with larger ORs are located on the same gene, it
appears thatKCNQ1may truly have a stronger signal in South
Asians than in white Europeans. However, the exceptionally
large effect size for KCNQ1 rs2237897 is likely to be inaccu-
rate, given the wide CIs and inconsistency with GWAS esti-
mates from Europeans and East Asians (OR 1.33, 95% CI
1.24–1.41) [41]. Moreover, the KCNQ1 rs2237897 associa-
tion was reported in only two studies among South Asians and
thus could be a product of the winner’s curse [42].
Fifteen GWAS signals for type 2 diabetes in white Euro-
peans, East Asians, and Singaporean Malay [43–46] were not
associated with type 2 diabetes in our South Asian meta-






























































Fig. 3 Venn diagram of SNPs
common to South Asians and
white Europeans and SNPs
unique to both groups. CENTD2
is also known as ARAP1. The
green box includes genes with
GWAS evidence for association
with type 2 diabetes; the pink box
includes genes with GWAS
evidence in white Europeans and
association with type 2 diabetes in
this meta-analysis; and yellow
with genes identified from a trans-
ethnic meta-analysis of South
Asians and white Europeans [49]
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sizes for ADAMTS9 rs4607103,CDC123 rs12779790, JAZF1
rs864746, KCNQ1 rs231362, DGKT-TMEM195 rs2191349
(also known as AGMO), GCK rs1799884, GCKR rs780094,
MTNR1B rs10830963, PROX1 rs340874, and TSPAN8
rs7961581 (Table 2) and either a true lack of association for
KCNJ11 rs5219, KCNQ1 rs2237895, NOTCH2 rs10923931,
THADA rs7578597 and WFS1 rs10010131 or significant
between-study heterogeneity since we were adequately
powered for the last five SNPs (Table 2). KCNJ11 rs5219 in
particular was close to significance (OR 1.19. 95% CI 0.98–
1.45) and demonstrated a high degree of heterogeneity
(I2=81%, p<0.01).
Comparison of effect sizes, RAF and risk alleles
between South Asians and white Europeans
In general when comparing effect sizes of SNPs associated
with type 2 diabetes from our meta-analysis with DIAGRAM
estimates in white Europeans, the risk from SNPs predispos-
ing to type 2 diabetes did not differ substantially between the
groups. However, the point estimates were more precise and
CIs tighter among the white Europeans because of the larger
sample size. Our observation of no significant difference in
risk estimates is not surprising because SNPs evaluated in
South Asians are selected for homogeneity as they were first
discovered in white Europeans and then replicated in South
Asians. If there is a difference in genetic risk between the
ethnic groups, it probably does not result from polymorphisms
common to both groups. The results of our paper are support-
ed by those recently published by DIAGRAM, the Asian
Genetic Epidemiology Network Type 2 Diabetes (AGEN-
T2D) Consortium, and the South Asian Type 2 Diabetes
(SAT2D) Consortium [49]. Their study also found effect
estimates for common SNPs predisposing to type 2 diabetes
to be homogenous among South Asians and white Europeans.
In addition to the recently published study, we show that the
gene score, which measures population burden in both groups,
does not differ. Our conclusion that the genetic risk for type 2
diabetes probably does not differ between the two ethnicities
is greatly strengthened by this recent publication.
Figure 3 depicts overlap between genes associated with
type 2 diabetes in South Asians and white Europeans.
Considerably more signals have been identified in white
Europeans due to the greater number of GWAS. Because a
majority of signals were replicated in our meta-analysis, it is
unlikely that they are unique to white Europeans. Rather,
larger GWAS with greater than 36,000 case/control pairs are
required to detect ORs as low as 1.05 with an RAF of 10%.
The four GWAS in South Asians represent about 25,704 cases
and 43,688 controls, therefore more GWAS in South Asians
alone will detect small effects and discover SNPs unique to
this group, and ultimately facilitate further elucidation of the
genetic basis of type 2 diabetes in this group.
We did not find a trend in RAFs; specifically, RAFs were
not consistently higher in South Asians. Risk alleles from six
SNPs in this analysis were the major/common alleles in both
ethnicities. Negative selection usually prevents risk alleles
from becoming common unless they are advantageous [50].
In the case of PPARG rs1801282, the risk allele is responsible
for increased fat storage and may have been advantageous in
ancient environments with unpredictable food supply and
high level of activity, but now predisposes to type 2 diabetes
[50]. However, to truly establish whether active selection of an
allele exists, systematic study of population differentiation is
warranted [51].
Testing novel SNPs discovered from South Asians GWAS
in white Europeans
Finally, we tested novel SNPs derived from South Asians in
white Europeans; only three were associated with type 2
diabetes. Interestingly, one of the novel SNPs, rs1048886, is
a functional missense mutation resulting in a change from
glutamine to arginine in the UPF0369 protein involved in
immune response [52]. Additionally, the G risk allele for
SGCG rs9552911 is not present in white Europeans. The
putative existence of private polymorphisms in South Asians
is supported by presence of assortative mating resulting from
prolonged geographical and cultural isolation of this region
from white Europeans [53]. Non-association of the remaining
seven dimorphic SNPs with type 2 diabetes in white Euro-
peans is quite puzzling as the risk alleles are present in this
group. DIAGRAM’s large sample ensures reasonable power;
for the lowest RAF of all eight SNPs, the DIAGRAM sample
had greater than 80% power to detect an OR of at least 1.07,
and therefore non-association may be due to substantially
different LD structures or lower effect sizes in white Euro-
peans because of ethnic specific gene–environment or gene–
gene interactions. We compared the LD structure for the seven
SNPs using HapMap data, and while not substantial, r2 values
with neighbouring SNPs have some differences (for example,
r2 of rs1048886 with neighbouring rs9455158 is 0.75 in white
Europeans and 0.87 in South Asians; r2 of rs3923113 with
neighbouring rs13432797 is 0.93 in white Europeans and 0.64
in South Asians). Fine mapping analyses will determine
whether the same functional variants are responsible for in-
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Fig. 4 Gene score of SNPs in South Asians and white Europeans. The
gene score was constructed using effect estimates and RAFs from SNPs
common to both groups
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the seven SNPs tag unique functional variants in South
Asians.
Population burden
No difference in genotype score between South Asians and
white Europeans was observed, which is consistent with our
finding that no trend exists for variation in RAFs. It should be
noted that our conclusion is based on an assumption of ho-
mogeneity in effect sizes between the groups, supported by
our primary analysis. Our conclusion is not consistent with
some literature, which shows a greater population burden in
South Asians based on unweighted genotype scores [54, 55].
However, while the cumulative genotype score for South
Asians was statistically higher than white Europeans in the
referenced study, the magnitude of the difference is small
(0.99 points on a scale that varied from 0 to 32) [54]. More-
over, unweighted scores consider the contribution from SNPs
with larger effects to be the same as that from SNPs with small
effects, and appear to discriminate less effectively between
disease states [56–59]. It should be noted, though, that the
genotype score calculation in the referenced paper is much
more direct than ours as it is based on primary data.
Strengths and limitations
This is the first meta-analysis that compares genetic risk of
type 2 diabetes in South Asians and white Europeans. Poten-
tial limitations of our study include use of unadjusted allelic
OR, which precluded us from accounting for SNP–type 2
diabetes associations altered by adiposity. Use of unadjusted
allelic OR depended largely on the unavailability of appropri-
ately adjusted data. However, we informally compared adjust-
ed estimates reported in the study with our unadjusted allelic
OR and found the adjustment to make little difference; for
example, the OR for GCKR rs780094 in the primary report
[55] was 0.87 (95% CI 0.72–1.05) after adjustment for age
and sex. In our study, the OR is 0.86 (95% CI 0.65–1.13).
Second, publication and time-lag biases may exist whereby
significant results are published more often than negative
studies. To minimise these biases, we conducted a thorough
search of literature and consulted experts to identify as many
eligible studies as possible. We were unable to produce funnel
plots to formally assess publication bias because fewer than
ten studies were used to meta-analyse a majority of SNPs.
Third, some SNPs in this meta-analysis were only investi-
gated in two cohorts and their summary estimates should be
interpreted with caution.
Finally, sample sizes varied with each SNP in South Asians
but were consistent for all SNPs in white Europeans, which
may create artificial differences between the groups as a result
of differences in precision. Our conclusions regarding the
genetic heterogeneity between South Asians and white
Europeans are applicable only to genetic risk from bi-allelic
common SNPs as our investigation was limited to this type of
variant.
Future directions
The question of why South Asians have a greater risk for type
2 diabetes remains unanswered from a genetic perspective as
risk from common SNPs predisposing to type 2 diabetes does
not differ. Our results are particularly important as they em-
phasise the need for future research to explore heritable epi-
genetic changes, epistasis and gene–environment interactions
to answer this question [60, 61], rather than focusing on
exploring differences in risk estimates and RAFs. Additional-
ly, differences in genetic risk may result from low-frequency
causal variants with large effects (rare variants) [62, 63]. The
existence of such rare variants can be investigated through
candidate gene, whole-genome or whole-exome sequencing.
In fact, discovery of rare variants for Crohn’s disease greatly
supports this paradigm [64]. Large-scale exon resequencing
around an MTNR1B SNP modestly associated with type 2
diabetes (OR between 1.10 and 1.15) identified four rare
variants that led to loss of melatonin binding and signalling
capacity (OR 5.67, 95% CI 2.17–14.82) [65]. Using a family-
based approach with multiple affected members or studying
founder populations can facilitate the identification of rare
variants in sequencing studies. Finally, systematic reviews
and primary studies comparing dietary intake and physical
activity patterns between South Asians and white Europeans
have noted considerable variation [66, 67], which may also
contribute to the differences observed between the two ethnic
groups.
Conclusions
Similar effect sizes for SNPs predisposing to type 2 diabetes
are apparent among South Asians and white Europeans, but
there is variation in RAFs. Additionally, some novel SNPs are
present in South Asians. Given the current literature, there is
no strong evidence to indicate that currently known genetic
variants explain the higher risk of type 2 diabetes in South
Asians compared with white Europeans.
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